Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Opening stock page...
Fetching company snapshot, pricing, and intelligence.
AI confidence 70% · prior close shown (market closed)
RedHill Biopharma Ltd. shows accelerating business momentum based on AlphaOS pipeline evidence.
Why it matters: Revenue +59% YoY in Q2 FY2025.
4 signals not yet derived from pipeline evidence
What it means for the thesis — synthesis, not a raw event feed.
Pipeline evidence · 33d ago
Reported figures for RedHill Biopharma Ltd. — research only, not investment advice.
Updated
What happened recently for RedHill Biopharma Ltd. (RDHL) — events, not interpretation.
Research & analysis only — not investment advice.
Investment snapshot
Prior close
$0.60
Market cap
$30.55B
Profitable
No
Revenue $4.08M
Net income
$-4.13M
FY Jul 22, 2026
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
Investment Snapshot above is the primary AlphaOS analysis for RedHill Biopharma Ltd. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Connected companies and research pages from the AlphaOS knowledge graph.
Follow RedHill Biopharma Ltd. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.